Project Grant HT94252510310
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$329K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
This federal Project Grant award, valued at $168,500.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research conducted by the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida, to cotarget Type 1 PRMTS and YAP1 in order to combat EGFR-mutant lung adenocarcinoma. The grant period runs from September 1, 2024 to August 31, 2025. The Moffitt Cancer Center is a nonprofit,...
This $995,267 federal Project Grant award was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The grant was awarded on June 1, 2024 to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., a National Cancer Institute-designated comprehensive cancer center located in Tampa,...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), has awarded a $328,575 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. This 3-year grant, with a start date of September 1, 2024, will support research aimed at "Reversing Exhaustion of Tumor-Infiltrating Lymphocytes for Improvement of Adoptive Cell Therapy." As a National Cancer Institute-designated comprehensive cancer...
This Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Texas Southwestern Medical Center. The $1,312,000 grant, with a period of performance from July 1, 2024 to June 30, 2028, will support research on biomarkers and mechanisms of acquired resistance to immunotherapy for renal cell carcinoma. This work aims to improve understanding and treatment of this form of kidney cancer, which is a...
The U.S. Department of Defense's Defense Health Agency awarded a $481,749 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 30, 2023 through September 29, 2026, will support research to dissect the spatial molecular architecture of the transformed cutaneous T cell lymphoma tumor microenvironment, with the goal of identifying novel...
This $1,339,689 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a study to identify and characterize metastasis-driving tumor cell subpopulations in localized stage III clear cell renal cell carcinoma. The research will be conducted by The Feinstein Institutes for Medical Research, a leading non-profit medical research organization, over a 4-year period from August 1, 2024 to July 31, 2028. The study aims to...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $2,837,644 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The funding will support "Translational Studies for Targeted Alpha-Particle Therapy for Rare Melanomas" over a 4-year period from September 1, 2023 to August 31, 2027. This project grant aims to advance research into innovative cancer therapies, specifically exploring...
This $1,619,065 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports the "DYNAMIC: DEVELOPMENT OF A BEHAVIORAL INTERVENTION FOR YOUNG ADULTS WITH ADVANCED CANCER" project at the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The 4-year grant, awarded on April 15, 2025, will fund the development and evaluation of a behavioral intervention to improve outcomes...
This $697,590 federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development program) supports research at the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) to evaluate B-T cell cross-talk within tertiary lymphoid structures in melanoma progression and immune checkpoint blockade. The grant, with a performance period from July 1, 2024 to June 30, 2027, aims to advance scientific understanding of...
This $769,073 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research to define and target cancer cell-intrinsic vulnerabilities in renal cell carcinoma. The grant was awarded to the Royal Institution for the Advancement of Learning / McGill Office of Sponsored Research Division, a private university affiliated with McGill University in Montreal, Canada. The research will be conducted from August 1, 2024...